skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

39 Total results for product and free and sample content found

Scrip

Infographic: The Netherlands, A Small Country With Big Ideas

By Jo Shorthouse 01 Feb 2019

As the EMA lowers the flags of the 28 EU nations that have flown outside its London offices for 24 years, and prepares to moves its HQ to the Netherlands, Scrip takes a look at Europe’s new pharma regulatory hub.

Topic Business strategies Brexit

Pink Sheet

'Rule Out No-Deal Brexit,' BIA Tells Government

By Ian Schofield 23 Jan 2019

The BioIndustry Association wants the government to rule out a “no-deal” Brexit, saying it would be bad for patients and the life sciences sector.

Topic Brexit Business strategies Strategy

Medtech Insight

UK To Demand 'Responsible Person' Be Physically Located In Country Under No-Deal Brexit

By Amanda Maxwell 10 Jan 2019

The recent no-deal Brexit notice from the UK government says that companies selling devices in the UK would need a "Responsible Person" in the UK if the firm is not based there. The government clarifies to Medtech Insight that such person must be physically present in the UK, and not simply have an address there.

Topic Brexit

Medtech Insight

EU Regulatory Roundup November 2018

By Amanda Maxwell 05 Dec 2018

The medtech sector was already quite overwhelmed with the new EU regulations and Brexit uncertainties. Now add into the mix the impact of the global journalistic Implant Files investigation.

Topic Brexit Medtech

Pink Sheet

The Tricky Task Of Bringing Smaller EU Countries Into The Fold

By Maureen ​ Kenny 12 Sep 2018

Clusters of excellence, competition as well as co-operation, Brexit, and aiming high. Danish Medicines Agency head Thomas Senderovitz talks national agencies and engagement in an interview with the Pink Sheet.

Topic Brexit Drug development landscape Drug approval

Pink Sheet

Brexit Likely To Force Refocusing Of Ambitious EU Network Strategy

By Maureen ​ Kenny 12 Sep 2018

The European Medicines Agency and drug regulators throughout the EU are having to invest huge amounts of time and effort in dealing with the fall-out from Brexit - and it hasn't even happened yet. Plans for working together on bigger issues agreed on a few years ago will likely have to change, senior regulator Thomas Senderovitz tells the Pink Sheet.

Topic Brexit Business strategies

Pink Sheet

Big Data In Medicines Regulation Will Need ‘Considerable Change In Mindset’

By Maureen ​ Kenny 12 Sep 2018

Changing mindsets, technologies outpacing regulatory frameworks, intense international collaboration, and the future of the randomized controlled clinical trial. Big data is forcing us to think big, senior European regulator Thomas Senderovitz tells the Pink Sheet.

Topic Brexit Business strategies

Medtech Insight

Notified Body Capacity: TEAM-NB Members Way Ahead But Picture Clouded By Brexit

By Amanda Maxwell 30 Aug 2018

With the pressure increasing on manufacturers to have their products reassessed under the current EU medical devices directives or under the new EU regulations, where can capacity be found?

Topic Brexit Business strategies

Scrip

Sanofi Top UK Exec Plans For Hard Brexit, Blasts 'Poor Access' To New Drugs

By Sten Stovall 22 Aug 2018

The managing director for Sanofi in the UK says clinical trials there will become less likely in future if access to innovative drugs doesn't improve, causing comparative standards of care to deteriorate.

Topic Brexit Business strategies Clinical trials

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: